No invoice flow, no payment processor outages, no friction
Just as importantly, the addition of extra ingredients creates a formulation that differs from the branded products, which compounders may use as a legal justification to avoid producing an outright copy of a brand-name drug.Recall Initiation Date: July 18, 2025Link: FDA Enforcement Report Semaglutide Company: Boothwyn Pharmacy, LLC (licensed compounding pharmacy)Location: Kennett Square, PennsylvaniaScope: Semaglutide, 2.5 mg/mL injection: .8 mL (186 vials), 2 mL (642 vials), 4 mL (648 vials)Drug Description: Treats type 2 diabetes and obesityRecall Reason: Subpotent drugs (which means they less than the specified amount of active ingredient)Recall Initiation Date: July 9, 2025Link: FDA Enforcement Report Semaglutide, Semaglutide/Cyanocobalamin, Tirzepatide, Tirzepatide/Cyanocobalamin Company: Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)Location: Englewood, ColoradoScope: Semaglutide: 5 mg/mL (164 pre-filled syringes)
Champaneri S, Wand GS, Malhotra SS, Casagrande SS, Golden SH
#CONMED #MedicalSalesCollege #imaginewhatwecoulddotogether Catherine Renfroe Catherine Renfroe 3yCatherine Renfroe shared thisHuge shoutout to Chris Bridges for helping us perform an ACDF today
